Related Experiment Video
Updated: Jun 4, 2025

Global Level Quantification of Histone Post-Translational Modifications in a 3D Cell Culture Model of Hepatic Tissue
Published on: May 5, 2022
Chemical perturbations impacting histone acetylation govern colorectal cancer differentiation
Pornlada Likasitwatanakul1,2,3,4, Zhixin Li1,2,3, Paul Doan1,3
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Abstract:
Dysregulated epigenetic programs that restrict differentiation, reactivate fetal genes, and confer phenotypic plasticity are critical to colorectal cancer (CRC) development. By screening a small molecule library targeting epigenetic regulators using our dual reporter system, we found that inhibiting histone deacetylase (HDAC) 1/2 promotes CRC differentiation and anti-tumor activity. Comprehensive biochemical, chemical, and genetic experiments revealed that on-target blockade of the HDAC1/2 catalytic domain mediated the differentiated phenotype. Unbiased profiling of histone posttranslational modifications induced by HDAC1/2 inhibition nominated acetylation of specific histone lysine residues as potential regulators of differentiation. Genome-wide assessment of implicated marks indicated that H3K27ac gains at HDAC1/2-bound regions associated with open chromatin and upregulation of differentiation genes upon HDAC1/2 inhibition. Disrupting H3K27ac by degrading acetyltransferase EP300 rescued HDAC1/2 inhibitor-mediated differentiation of a patient-derived CRC model using single cell RNA-sequencing. Genetic screens revealed that DAPK3 contributes to CRC differentiation induced by HDAC1/2 inhibition. These results highlight the importance of specific chemically targetable histone modifications in governing cancer cell states and epigenetic reprogramming as a therapeutic strategy in CRC.
Insights
Inhibiting histone deacetylase (HDAC) 1/2 promotes colorectal cancer (CRC) differentiation and anti-tumor activity by altering histone acetylation. This epigenetic reprogramming highlights a potential therapeutic strategy for CRC.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- Dysregulated epigenetic programs are critical to colorectal cancer (CRC) development, promoting uncontrolled cell growth and plasticity.
- Histone deacetylases (HDACs) play a key role in regulating gene expression and cellular differentiation.
- Targeting epigenetic regulators offers a promising avenue for novel CRC therapies.
Purpose of the Study:
- To investigate the role of histone deacetylase 1/2 (HDAC1/2) inhibition in promoting colorectal cancer differentiation.
- To elucidate the epigenetic mechanisms underlying HDAC1/2 inhibition-induced anti-tumor activity.
- To identify potential therapeutic strategies for colorectal cancer based on epigenetic reprogramming.
Main Methods:
- Screening of a small molecule library targeting epigenetic regulators using a dual reporter system.
- Biochemical, chemical, and genetic experiments to analyze HDAC1/2 function and inhibition.
- Profiling of histone posttranslational modifications and genome-wide assessment of histone marks (e.g., H3K27ac).
- Single-cell RNA-sequencing and genetic screens to identify contributing factors like EP300 and DAPK3.
Main Results:
- Inhibition of HDAC1/2 promotes colorectal cancer differentiation and anti-tumor activity through blockade of the catalytic domain.
- HDAC1/2 inhibition leads to increased H3K27ac at specific genomic regions, associated with open chromatin and differentiation gene upregulation.
- Degradation of EP300 rescues HDAC1/2 inhibitor-mediated differentiation, and DAPK3 contributes to this process.
- Specific histone modifications are crucial in governing cancer cell states.
Conclusions:
- HDAC1/2 inhibition represents a viable therapeutic strategy for colorectal cancer by inducing differentiation.
- Targeting specific histone modifications, such as H3K27ac, is key to epigenetic reprogramming in CRC.
- Understanding the interplay between epigenetic regulators and histone modifications can lead to novel cancer treatments.
Related Concept Videos
Spreading of Chromatin Modifications
Writers
The writer...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Variants at the Centromere
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Epigenetic Regulation
X-chromosome...

